Latest

July 2024 iConquerMS Spotlight

iConquerMS will launch the largest study ever on a new treatment for MS fatigue.

Research studies include one for Kesimpta users, exploration into childhood experiences, and a study on exercise and wellness for wheelchair users.

Your donation to ACP enables iConquerMS to bring together all people affected by MS to understand the disease and search for solutions.

Participate in research aimed at learning more about the relationship between exercise and anxiety in people with MS, or exploring how women with MS

Not enough time to read an entire newsletter? Our February newsletter snapshot contains the highlights in a quick, easy to read format.

Researchers are looking into the benefits and risks of alternative treatments for MS. Here are three recent studies with promising results!

Our ACP team is on the rise! This month, we are thrilled to welcome Grace Okafor. Spend a moment getting to know

We know how important research is to you, so this month we’re featuring new data on three popular complementary treatments for MS.

We know how important research is to you, so this month we’re bringing you highlights from the 2023 Leadership Summit. Meet Jen, a new